GLP-1 Drugs Work.
Muscle Loss Doesn't Have To.
40% of the weight you lose on Ozempic or Mounjaro can be lean muscle — not fat. Here's the science behind why, and what the evidence actually supports for preventing it.
The muscle-loss problem in three numbers
Recent articles
BPC-157: The Science Behind the Most Researched Gut and Connective Tissue Peptide
What the preclinical literature shows about BPC-157: gut healing, connective tissue repair, angiogenesis mechanisms, and the July 2026 FDA regulatory review.
What Is an Epigenetic Age Test? The Science Behind Biological Age Tracking
TruDiagnostic's TruAge measures DNA methylation to estimate biological age. Here's what the science shows — and why it matters for GLP-1 users.
GLP-1 Muscle Loss: The Science + What You Can Actually Do About It
GLP-1 drugs cause 40–45% lean mass loss on average. Here's the science behind why — and the evidence-based strategies most worth your attention.
The GLP-1 Protein Problem: Why You're Not Getting Enough and How to Fix It
GLP-1 users typically eat less than half the protein their muscles need. Here's the research-backed target, why the gap is so common, and how to close it.
Free: GLP-1 Muscle Protocol Checklist
The research-backed moves that actually reduce lean mass loss on GLP-1 therapy — protein targets, lifting minimums, what to track, and when. One email. No spam.
We respect your privacy. No spam, ever.